State officials and industry groups are raising concerns about USDA's new regulations for hemp, with some officials suggesting that the department delay some "unworkable" portions of an interim final rule that was released last fall.
Two consumers have filed a class-action lawsuit against a California CBD company for selling unapproved drugs, dietary supplements and foods, the latest in a series of suits that have hit the CBD industry since the Food and Drug Administration sent warning letters to 15 companies last month.
Warning letters sent by the Food and Drug Administration to 15 producers and sellers of CBD products show the agency is serious about enforcing current prohibitions on the marketing of goods containing cannabidiol, the non-psychoactive chemical contained in hemp.
CBD products are marketed almost everywhere these days, and hemp farmers are counting on this new, emerging market to bolster their revenues. However, the U.S. Food and Drug Administration (FDA) is stepping up its warnings on CBD in dietary supplements and food products
Nearly a year after the 2018 farm bill legalized industrial hemp production, the business community continues to seek answers to questions about testing and marketing of products derived from the crop, the commercial potential of which has sparked interest throughout the country.